Almac has the most comprehensive range of integrated drug development services available to the biopharmaceutical industry.  Employing over 2,000 highly skilled individuals, the privately owned company is headquartered in Craigavon, Northern Ireland and has extensive facilities in the UK and US. Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business.

Almac's world-class pharmaceutical solutions extend from research, through development, to the commercialisation of product:

• Comprehensive genomic and bioinformatics services
• Cancer genomics contract research
• Route design and synthesis of APIs (including potent, peptide and chiral compounds)
• Synthesis and formulation of labelled compounds
• Comprehensive analytical and stability testing services

• Formulation, process optimisation and analytical development
• Clinical manufacture, blinding, packaging and randomised labelling
• Technology solutions including IVR / Web based services, EDC and ePRO
• EU import testing, QP release and global distribution of clinical product

• Commercial scale manufacture of intermediates and APIs
• Commercial scale manufacture of solid, oral dosage forms
• Primary / secondary packaging and labelling
• EU import testing, QP release and global distribution of commercial product